clevidipine has been researched along with lu 135252 in 1 studies
Studies (clevidipine) | Trials (clevidipine) | Recent Studies (post-2010) (clevidipine) | Studies (lu 135252) | Trials (lu 135252) | Recent Studies (post-2010) (lu 135252) |
---|---|---|---|---|---|
127 | 19 | 62 | 196 | 13 | 14 |
Protein | Taxonomy | clevidipine (IC50) | lu 135252 (IC50) |
---|---|---|---|
Endothelin receptor type B | Homo sapiens (human) | 0.016 | |
Endothelin-1 receptor | Homo sapiens (human) | 0.0008 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gradman, AH; Vivas, Y | 1 |
1 review(s) available for clevidipine and lu 135252
Article | Year |
---|---|
New drugs for hypertension: what do they offer?
Topics: Adrenergic beta-Antagonists; Amides; Antihypertensive Agents; Benzopyrans; Blood Pressure; Calcium Channel Blockers; Drugs, Investigational; Endothelin A Receptor Antagonists; Ethanolamines; Fumarates; Humans; Hypertension; Nebivolol; Phenylpropionates; Pyridines; Pyrimidines; Renin; Treatment Outcome | 2006 |